目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 ORGAN PRESERVATION MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 ORGAN PRESERVATION MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 7 ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ORGAN PRESERVATION MARKET (2021-2026)
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET RANKING ANALYSIS
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ORGAN PRESERVATION MARKET

3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 12 ORGAN PRESERVATION MARKET, BY SOLUTION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 ORGAN PRESERVATION MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHIC ANALYSIS: ORGAN PRESERVATION MARKET

4 PREMIUM INSIGHTS (Page No. - 52)
4.1 ORGAN PRESERVATION MARKET OVERVIEW
FIGURE 17 RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE GROWTH IN THE GLOBAL ORGAN PRESERVATION MARKET
4.2 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION & COUNTRY
FIGURE 18 THE UNIVERSITY OF WISCONSIN SOLUTION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET IN 2020
4.3 ORGAN PRESERVATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
4.4 ORGAN PRESERVATION MARKET, BY REGION (2019-2026)
FIGURE 20 NORTH AMERICA TO DOMINATE THE ORGAN PRESERVATION MARKET TILL 2026
4.5 ORGAN PRESERVATION MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 56)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 MARKET DYNAMICS: ORGAN PRESERVATION MARKET
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population and subsequent growth in cases of multiple organ failure
TABLE 4 GROWTH IN GERIATRIC POPULATION (ABOVE-65 AGE GROUP), BY REGION, 2019 VS. 2050 (MILLION)
5.2.1.2 Increasing initiatives to promote public awareness and encourage organ donation
5.2.1.3 Rising number of organ donors and growing adoption of solid organ transplantation procedures
TABLE 5 NUMBER OF ORGAN DONATIONS, 2020
5.2.2 RESTRAINTS
5.2.2.1 High cost of organ transplantation
5.2.2.2 Religious concerns and misconceptions associated with organ donation
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare investments
5.2.4 CHALLENGES
5.2.4.1 Significant gap between the number of organs donated and organs required annually
5.2.4.2 Development of artificial organs
5.3 INDUSTRY TRENDS
5.3.1 SINGLE-PORT ROBOT-ASSISTED KIDNEY TRANSPLANT
5.3.2 PIG-TO-HUMAN XENOTRANSPLANTATION
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT FROM NEW ENTRANTS
5.4.2 THREAT FROM SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 PRICING ANALYSIS
TABLE 7 AVERAGE SELLING PRICE OF ORGAN PRESERVATION BY SOLUTION AND BY ORGANS
5.6 ECOSYSTEM ANALYSIS
FIGURE 22 ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 23 ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR ORGAN PRESERVATION
FIGURE 24 PATENT PUBLICATION TRENDS (2011-2022)
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ORGAN PRESERVATION PATENTS (JANUARY 2011-FEBRUARY 2022)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR ORGAN PRESERVATION PATENTS (JANUARY 2011-FEBRUARY 2022)
TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS IN THE ORGAN PRESERVATION MARKET, 2020-2021
5.9 REGULATORY LANDSCAPE
5.9.1 NORTH AMERICA
5.9.1.1 US
5.9.1.2 Canada
5.9.2 EUROPE
5.9.3 ASIA PACIFIC
5.10 IMPACT OF COVID-19 ON THE ORGAN PRESERVATION MARKET

6 ORGAN PRESERVATION MARKET, BY SOLUTION (Page No. - 73)
6.1 INTRODUCTION
TABLE 9 ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 10 ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.2 UNIVERSITY OF WISCONSIN
6.2.1 UW SOLUTIONS COMPRISE METABOLICALLY INERT SUBSTRATES, WHICH ENABLE BETTER TRANSPLANTATION OUTCOMES—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 11 ORGAN PRESERVATION MARKET FOR UW SOLUTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
6.3 CUSTODIOL HTK
6.3.1 DESPITE ITS LOW COST AND EASY DIFFUSION, THE DEMAND FOR HTK HAS DECLINED IN RECENT YEARS—A KEY FACTOR LIMITING MARKET GROWTH
TABLE 12 ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK SOLUTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
6.4 PERFADEX
6.4.1 LAUNCH OF PERFADEX PLUS TO DRIVE MARKET GROWTH
TABLE 13 ORGAN PRESERVATION MARKET FOR PERFADEX SOLUTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
6.5 OTHER SOLUTIONS
TABLE 14 OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 ORGAN PRESERVATION MARKET, BY TECHNIQUE (Page No. - 80)
7.1 INTRODUCTION
TABLE 15 COMPARISON OF THE METHODS USED FOR ORGAN PRESERVATION
TABLE 16 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 17 ORGAN PRESERVATION TECHNIQUES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2 STATIC COLD STORAGE
7.2.1 STATIC COLD STORAGE IS THE MOST WIDELY ADOPTED METHOD— A KEY FACTOR DRIVING MARKET GROWTH
TABLE 18 STATIC COLD STORAGE: ADVANTAGES & DISADVANTAGES
TABLE 19 ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE, BY COUNTRY, 2019-2026 (USD MILLION)
7.3 HYPOTHERMIC MACHINE PERFUSION
7.3.1 ADVANTAGES ASSOCIATED WITH HYPOTHERMIC MACHINE PERFUSION, SUCH AS ENHANCED ORGAN PRESERVATION QUALITY AND SURVIVAL RATE, TO DRIVE MARKET GROWTH
TABLE 20 HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES
TABLE 21 ORGAN PRESERVATION MARKET FOR HYPOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2019-2026 (USD MILLION)
7.4 NORMOTHERMIC MACHINE PERFUSION
7.4.1 TECHNOLOGICAL DEVELOPMENTS AND ADVANTAGES OF NORMOTHERMIC MACHINE PERFUSION TO DRIVE MARKET GROWTH
TABLE 22 NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES
TABLE 23 ORGAN PRESERVATION MARKET FOR NORMOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2019-2026 (USD MILLION)

8 ORGAN PRESERVATION MARKET, BY ORGAN TYPE (Page No. - 87)
8.1 INTRODUCTION
FIGURE 27 NUMBER OF ORGAN TRANSPLANTS GLOBALLY, 2020
TABLE 24 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
8.2 KIDNEYS
8.2.1 KIDNEYS ARE THE MOST TRANSPLANTED ORGANS GLOBALLY—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 25 NUMBER OF KIDNEY TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
TABLE 26 TOTAL KIDNEY TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
FIGURE 28 US: NUMBER OF ESRD PATIENTS ADDED TO THE WAITING LIST FOR KIDNEY TRANSPLANTS, 2000-2018
FIGURE 29 US: COUNT AND RATE OF KIDNEY TRANSPLANTS IN PATIENTS UNDERGOING DIALYSIS, 2000-2018
TABLE 27 KIDNEY PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 LIVER
8.3.1 RISING PREVALENCE OF LIVER DISEASE AND GROWING CASES OF LIVER FAILURE TO DRIVE THE DEMAND FOR LIVER TRANSPLANTATION PROCEDURES
TABLE 28 NUMBER OF LIVER TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
TABLE 29 TOTAL LIVER TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
TABLE 30 LIVER PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.4 LUNGS
8.4.1 GROWTH IN COPD INCIDENCE BOOSTS THE DEMAND FOR PRESERVATION TECHNIQUES AND PRODUCTS
TABLE 31 US: PREVALENCE OF COPD CASES IN MAJOR STATES, BY GENDER, 2018
TABLE 32 NUMBER OF LUNG TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
TABLE 33 TOTAL LUNG TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
TABLE 34 LUNG PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.5 HEART
8.5.1 ADVANCEMENTS IN HEART PRESERVATION TECHNIQUES TO DRIVE MARKET GROWTH
TABLE 35 NUMBER OF HEART TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
TABLE 36 TOTAL HEART TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
TABLE 37 HEART PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.6 PANCREAS
8.6.1 GROWING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
TABLE 38 NUMBER OF PANCREAS TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
TABLE 39 TOTAL PANCREAS TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
TABLE 40 PANCREAS PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

9 ORGAN PRESERVATION MARKET, BY END USER (Page No. - 101)
9.1 INTRODUCTION
TABLE 41 ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2 ORGAN TRANSPLANT CENTERS
9.2.1 ORGAN TRANSPLANT CENTERS ARE THE MAJOR END USERS OF ORGAN PRESERVATION SOLUTIONS
FIGURE 30 NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 42 ORGAN PRESERVATION MARKET FOR ORGAN TRANSPLANT CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
9.3 HOSPITALS
9.3.1 INCREASING INCIDENCE OF ACCIDENTAL INJURIES AND CHRONIC DISEASES TO DRIVE MARKET GROWTH
TABLE 43 ORGAN PRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2019-2026 (USD MILLION)
9.4 SPECIALTY CLINICS
9.4.1 INCREASING PREVALENCE OF END-STAGE DISEASES AND ORGAN FAILURE TO DRIVE MARKET GROWTH
TABLE 44 ORGAN PRESERVATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)

10 ORGAN PRESERVATION MARKET, BY REGION (Page No. - 107)
10.1 INTRODUCTION
FIGURE 31 CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE ORGAN PRESERVATION MARKET
FIGURE 32 TOTAL NUMBER OF ORGAN TRANSPLANTS IN SOME COUNTRIES, 2019 VS. 2020
TABLE 45 ORGAN PRESERVATION MARKET, BY REGION, 2019-2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: ORGAN PRESERVATION MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 47 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 48 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 49 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 50 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2.1 US
10.2.1.1 Growing cases of organ failure and underlining diseases to drive the demand for organ transplantation in the US
TABLE 51 NUMBER OF ORGAN TRANSPLANTS IN THE US, 2017-2020
TABLE 52 WAITING LIST FOR ORGAN TRANSPLANTS (AS OF JANUARY 2022)
FIGURE 34 US: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 53 US: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 54 US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 55 US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 56 US: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Improved organ donation rates to drive growth in the market in Canada
TABLE 57 CANADA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
FIGURE 35 CANADA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020
TABLE 58 ACTIVE WAITING LIST FOR ORGAN TRANSPLANTS, 2019
TABLE 59 CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 60 CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 61 CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 62 CANADA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3 EUROPE
TABLE 63 EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 64 EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 65 EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 66 EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 67 EUROPE: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.1 FRANCE
10.3.1.1 Increasing number of organ transplants and organ donor registrations promote future growth of the organ preservation market in France
TABLE 68 FRANCE: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
FIGURE 36 FRANCE: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 69 FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 70 FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 71 FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 72 FRANCE: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.2 SPAIN
10.3.2.1 Spain registered the second-highest deceased organ donation rate globally—a key factor driving market growth
TABLE 73 SPAIN: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 74 SPAIN: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST, 2017-2019
FIGURE 37 SPAIN: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020
TABLE 75 SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 76 SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 77 SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 78 SPAIN: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Growth in the market in the UK is mainly driven by the increasing disease/disorder prevalence and favorable regulations
TABLE 79 UK: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 80 UK: TOTAL NUMBER OF PATIENTS ON THE ACTIVE ORGAN TRANSPLANT WAITING LIST (AS OF APRIL 8, 2021)
FIGURE 38 UK: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020
TABLE 81 UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 82 UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 83 UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 84 UK: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Declining rate of organ donation and transplant due to COVID-19 limited market growth in 2020
TABLE 85 ITALY: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 86 ITALY: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST, 2020
FIGURE 39 ITALY: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 87 ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 88 ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 89 ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 90 ITALY: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.5 GERMANY
10.3.5.1 Low organ donation and transplant rates form a major concern for the German market
TABLE 91 GERMANY: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 92 GERMANY: TOTAL NUMBER OF PATIENTS ACTIVE ON THE ORGAN TRANSPLANT WAITING LIST, 2019-2021
FIGURE 40 GERMANY: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 93 GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 94 GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 95 GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 96 GERMANY: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 97 ROE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 98 ROE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 99 ROE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 100 ROE: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 41 ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT
TABLE 101 APAC: ORGAN PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 102 APAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 103 APAC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 104 APAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 105 APAC: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Growing awareness and adoption of laws favoring organ donation to drive market growth in China
TABLE 106 CHINA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
FIGURE 42 CHINA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 107 CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 108 CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 109 CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 110 CHINA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.2 INDIA
10.4.2.1 Lack of awareness is a key barrier to market growth in India
FIGURE 43 INDIA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 111 INDIA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 112 INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 113 INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 114 INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 115 INDIA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Religious beliefs and lack of awareness limit market growth in Japan
TABLE 116 JAPAN: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 117 JAPAN: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST (AS OF MARCH 31, 2021)
FIGURE 44 JAPAN: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 118 JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 119 JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 120 JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 121 JAPAN: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 122 ROAPAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 123 ROAPAC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 124 ROAPAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 125 ROAPAC: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 IMPLEMENTATION OF EDUCATIONAL PROGRAMS TO TRAIN PROFESSIONALS ON ORGAN RETRIEVAL AND TRANSPLANT PROCEDURES TO DRIVE MARKET GROWTH
TABLE 126 BRAZIL: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
FIGURE 45 BRAZIL: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
TABLE 127 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 128 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 129 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 130 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPLEMENTATION OF GOVERNMENT INITIATIVES AND POLICIES TO DRIVE MARKET GROWTH
TABLE 131 SAUDI ARABIA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 132 ISRAEL: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
TABLE 133 UAE: NUMBER OF ORGAN TRANSPLANTS, 2018-2020
TABLE 134 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 160)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE ORGAN PRESERVATION MARKET
11.3 MARKET RANKING ANALYSIS
TABLE 138 ORGAN PRESERVATION MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020
11.4 COMPETITIVE BENCHMARKING
11.4.1 FOOTPRINT OF COMPANIES IN THE ORGAN PRESERVATION MARKET
TABLE 139 COMPANY ORGAN PRESERVATION SOLUTION & DEVICE FOOTPRINT
TABLE 140 COMPANY TECHNIQUE FOOTPRINT
TABLE 141 COMPANY REGIONAL FOOTPRINT
11.5 COMPETITIVE LEADERSHIP MAPPING
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 46 ORGAN PRESERVATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
11.6 COMPETITIVE SCENARIO
11.6.1 PRODUCT LAUNCHES & APPROVALS
TABLE 142 PRODUCT LAUNCHES & APPROVALS, 2018-2022
11.6.2 DEALS
TABLE 143 DEALS, 2018-2022
11.6.3 OTHER DEVELOPMENTS
TABLE 144 OTHER DEVELOPMENTS, 2018-2022

12 COMPANY PROFILES (Page No. - 173)
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 PARAGONIX TECHNOLOGIES, INC.
TABLE 145 PARAGONIX TECHNOLOGIES, INC.: BUSINESS OVERVIEW
12.1.2 XVIVO PERFUSION AB
TABLE 146 XVIVO PERFUSION AB: BUSINESS OVERVIEW
FIGURE 47 XVIVO PERFUSION AB: COMPANY SNAPSHOT (2020)
12.1.3 DR. FRANZ KÖHLER CHEMIE GMBH
TABLE 147 DR. FRANZ KÖHLER CHEMIE GMBH: BUSINESS OVERVIEW
12.1.4 ESSENTIAL PHARMACEUTICALS, LLC (A SUBSIDIARY OF ACCORD HEALTHCARE)
TABLE 148 ESSENTIAL PHARMACEUTICALS, LLC: BUSINESS OVERVIEW
12.1.5 TRANSMEDICS, INC.
TABLE 149 TRANSMEDICS, INC.: BUSINESS OVERVIEW
12.1.6 ORGANOX LIMITED
TABLE 150 ORGANOX LIMITED: BUSINESS OVERVIEW
12.1.7 21ST CENTURY MEDICINE
TABLE 151 21ST CENTURY MEDICINE: BUSINESS OVERVIEW
12.1.8 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
TABLE 152 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.1.9 BRIDGE TO LIFE LIMITED
TABLE 153 BRIDGE TO LIFE LIMITED: BUSINESS OVERVIEW
12.1.10 WATERS MEDICAL SYSTEMS LLC
TABLE 154 WATERS MEDICAL SYSTEMS: BUSINESS OVERVIEW
12.1.11 PRESERVATION SOLUTIONS, INC.
TABLE 155 PRESERVATION SOLUTIONS, INC.: BUSINESS OVERVIEW
12.1.12 CARNAMEDICA
TABLE 156 CARNAMEDICA: BUSINESS OVERVIEW
12.1.13 TRANSPLANT BIOMEDICALS
TABLE 157 TRANSPLANT BIOMEDICALS: BUSINESS OVERVIEW
12.1.14 INSTITUT GEORGES LOPEZ
TABLE 158 INSTITUT GEORGES LOPEZ: BUSINESS OVERVIEW
12.1.15 GLOBAL TRANSPLANT SOLUTIONS
TABLE 159 GLOBAL TRANSPLANT SOLUTIONS: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 AVIONORD
TABLE 160 AVIONORD: BUSINESS OVERVIEW
12.2.2 ORGAN PRESERVATION SOLUTIONS LTD.
TABLE 161 ORGAN PRESERVATION SOLUTIONS LTD.: BUSINESS OVERVIEW
12.2.3 EBERS
TABLE 162 EBERS: BUSINESS OVERVIEW
12.2.4 S.A.L.F.
TABLE 163 S.A.L.F.: BUSINESS OVERVIEW
12.2.5 BIOCHEFA
TABLE 164 BIOCHEFA: BUSINESS OVERVIEW
12.2.6 VASCULAR PERFUSION SOLUTIONS, INC.
TABLE 165 VASCULAR PERFUSION SOLUTIONS, INC.: BUSINESS OVERVIEW
12.2.7 TX INNOVATIONS
TABLE 166 TX INNOVATIONS: BUSINESS OVERVIEW

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 210)
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS